Dec 6, 2019 2:17 PM
BACK TO TOP
KSE 100
40,819.83
178.73
(0.44%)
KSE ALL
28,919.50
207.80
(0.72%)
KSE 30
18,645.55
74.40
(0.40%)
KMI 30
64,434.52
463.18
(0.72%)
KMI ALL
18,960.01
142.70
(0.76%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.223.15
0.47
(0.21%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Dec 6, 2019 12:20 PM
REG
FUT
ODL
Open
221.99
High
225.00
Low
218.05
Volume
59,900
CIRCUIT BREAKER
211.55 — 233.81
DAY RANGE
218.05 — 225.00
52-WEEK RANGE
86.87 — 236.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
222.68
VAR
12.65
HAIRCUT
16.50
P/E Ratio (TTM)
24.99
1-Year Change *
37.21%
YTD Change *
54.64%
Open
219.00
High
232.99
Low
219.00
Close
225.00
Change
1.04%
LDCP
222.68
Volume
29
Total Trades
5
CIRCUIT BREAKER
200.42 — 244.94
DAY RANGE
219.00 — 232.99
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was subsequently converted into a public limited company. The Company is primarily engaged in the imports, manufacture and sale of pharmaceuticals products and medical devices.

KEY PEOPLE
Mrs. Akhter Khalid WaheedChairman
Mr. Osman Khalid WaheedCEO
Mr. Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
6,736,193.57
Shares
30,186,841
Free Float
10,565,394
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2019Transmission of Quarterly Report for the Period Ended 30-09-2019 View   PDF
Oct 25, 2019Financial Results for the Quarter Ended 2019-09-30 View   PDF
Oct 4, 2019Transmission of Annual Report for the Year Ended 30-06-2019 View   PDF
Sep 23, 2019Financial Results for the Year Ended 2019-06-30 View   PDF
Sep 23, 2019Financial Results for the Quarter Ended 2019-06-30 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the Period Ended 31-03-2019 View   PDF
Apr 17, 2019Financial Results for the Quarter Ended 2019-03-31 View   PDF
Feb 28, 2019Transmission of Quarterly Report for the Period Ended 2018-12-31 View   PDF
Feb 25, 2019Financial Result Results for the Quarter Ended 2018-12-31 View   PDF
Oct 30, 2018Transmission of Quarterly Report for the Period Ended 2018-09-30 View   PDF
DateTitleDocument
Oct 31, 2019Certified Copies of Resolutions passed in the Annual General Meeting View   PDF
Oct 18, 2019Board Meeting View   
Oct 2, 2019Notice of Annual General Meeting View   PDF
Sep 13, 2019Board Meeting View   
Apr 11, 2019Board Meeting View   
Apr 10, 2019Board Meeting View   
Feb 15, 2019Board Meeting View   
Oct 19, 2018Board Meeting View   
Oct 5, 2018Notice of Annual General Meeting View   PDF
Sep 18, 2018Board Meeting View   
DateTitleDocument
Nov 18, 2019Corporate Briefing Session (CBS) View   PDF
Nov 13, 2019Credit of Final Cash Dividend View   
Jul 26, 2019Change of Chief Financial Officer View   
Mar 15, 2019Credit of Interim Cash Dividend View   
Feb 28, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Feb 26, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Nov 9, 2018Credit of Final Cash Dividend View   
Sep 6, 2018Change in Beneficial Ownership of Director View   
Oct 25, 2017Dispatch of Final Dividend Warrants View   
Jul 17, 2017Latest List of Directors and appointment of Chief Executive Officer and Chairperson View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales5,180,8044,459,3234,311,44210,186,496
Profit after Taxation251,04695,406393,6652,104,486
EPS8.323.1613.0469.72
Q1 2020Q3 2019Q2 2019Q1 2019
Sales1,188,8281,242,0281,297,4061,046,141
Profit after Taxation83,00213,13276,95264,617
EPS2.750.432.552.14
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)39.4935.2041.2140.34
Net Profit Margin (%)4.852.149.1320.66
EPS Growth (%)163.29(75.77)(81.30)181.13
PEG0.08(0.81)(0.36)0.08

Payouts

DateFinancial ResultsDetailsBook Closure
September 23, 2019 2:47 PM30/06/2019(YR) 40%(F) (D) 18/10/2019 - 25/10/2019
February 25, 2019 12:50 PM31/12/2018(HYR) 20% (i) (D) 08/03/2019 - 14/03/2019
September 25, 2018 3:08 PM30/06/2018(YR) 20% (D) 20/10/2018 - 27/10/2018
August 30, 2017 3:38 PM30/06/2017(YR) 40% (D) M /10/2017 - 18/10/2017
January 30, 2017 3:47 PM31/12/2016(HYR) 30%(I) (D) 11/02/2017 - 19/02/2017
August 30, 2016 10:16 AM30/06/2016(YR) 120% (F) (D) 11/10/2016 - 20/10/2016
January 26, 2016 9:54 AM31/12/2015(HYR) 100%(I) (D) 20/02/2016 - 26/02/2016
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
February 16, 2015 3:52 PM31/12/2015(HYR) 40%(I) (D) 13/03/2015 - 20/03/2015

Financial Reports